Clinical Trial Update: Pharmacokinetics of Single-Dose Liposomal Bupivacaine in Surgeon Performed Intercostal Nerve Blocks [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the pharmacokinetics of single-dose liposomal bupivacaine used in surgeon-performed intercostal nerve blocks for thoracic procedures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thoracic Disease

Drugs mentioned

• Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: University of Virginia | Conditions: Thoracic | Phase 4 | Status: COMPLETED | Results posted: 2022-05-23